MDWD
Price:
$16.48
Market Cap:
$177.76M
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.[Read more]
Industry
Biotechnology
IPO Date
2014-03-20
Stock Exchange
NASDAQ
Ticker
MDWD
According to MediWound Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 180.32M. This represents a change of 67.03% compared to the average of 107.96M of the last 4 quarters.
The mean historical Enterprise Value of MediWound Ltd. over the last ten years is 83.33M. The current 180.32M Enterprise Value has changed 21.54% with respect to the historical average. Over the past ten years (40 quarters), MDWD's Enterprise Value was at its highest in in the June 2018 quarter at 181.00M. The Enterprise Value was at its lowest in in the September 2022 quarter at 29.90M.
Average
83.33M
Median
82.03M
Minimum
34.23M
Maximum
142.57M
Discovering the peaks and valleys of MediWound Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 151.70%
Maximum Annual Enterprise Value = 142.57M
Minimum Annual Increase = -68.96%
Minimum Annual Enterprise Value = 34.23M
Year | Enterprise Value | Change |
---|---|---|
2023 | 86.15M | 151.70% |
2022 | 34.23M | -37.36% |
2021 | 54.64M | -35.75% |
2020 | 85.04M | 7.62% |
2019 | 79.02M | -23.55% |
2018 | 103.37M | 47.39% |
2017 | 70.13M | -1.54% |
2016 | 71.23M | -50.04% |
2015 | 142.57M | 33.36% |
2014 | 106.90M | -68.96% |
The current Enterprise Value of MediWound Ltd. (MDWD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
58.34M
5-year avg
67.82M
10-year avg
83.33M
MediWound Ltd.’s Enterprise Value is less than Foghorn Therapeutics Inc. (417.24M), greater than Eliem Therapeutics, Inc. (119.64M), greater than Sutro Biopharma, Inc. (57.26M), greater than Dyadic International, Inc. (56.56M), less than Crinetics Pharmaceuticals, Inc. (4.93B), greater than Inhibrx Biosciences, Inc. (9.32M), less than Merus N.V. (2.68B), less than Lyell Immunopharma, Inc. (216.40M), greater than Kronos Bio, Inc. (5.32M), greater than Aerovate Therapeutics, Inc. (46.23M), less than Keros Therapeutics, Inc. (1.75B), less than Syndax Pharmaceuticals, Inc. (1.24B), less than Mineralys Therapeutics, Inc. (523.81M), less than Replimune Group, Inc. (984.10M), less than Ocular Therapeutix, Inc. (1.04B), less than Veracyte, Inc. (2.81B), less than Avidity Biosciences, Inc. (4.80B), less than SpringWorks Therapeutics, Inc. (2.83B), less than Monte Rosa Therapeutics, Inc. (439.72M), less than Nkarta, Inc. (201.38M), greater than Generation Bio Co. (163.63M), less than Sana Biotechnology, Inc. (551.82M),
Company | Enterprise Value | Market cap |
---|---|---|
417.24M | $435.85M | |
119.64M | $342.68M | |
57.26M | $206.97M | |
56.56M | $57.11M | |
4.93B | $5.20B | |
9.32M | $203.82M | |
2.68B | $3.11B | |
216.40M | $265.26M | |
5.32M | $54.49M | |
46.23M | $76.81M | |
1.75B | $2.27B | |
1.24B | $1.37B | |
523.81M | $621.09M | |
984.10M | $1.02B | |
1.04B | $1.39B | |
2.81B | $3.07B | |
4.80B | $5.16B | |
2.83B | $2.90B | |
439.72M | $521.60M | |
201.38M | $172.89M | |
163.63M | $91.51M | |
551.82M | $582.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediWound Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MediWound Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is MediWound Ltd.'s Enterprise Value?
What is the highest Enterprise Value for MediWound Ltd. (MDWD)?
What is the 3-year average Enterprise Value for MediWound Ltd. (MDWD)?
What is the 5-year average Enterprise Value for MediWound Ltd. (MDWD)?
How does the current Enterprise Value for MediWound Ltd. (MDWD) compare to its historical average?